1Fung J, Abu Elmagd K, Jain A, et al.A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.Transplant Proc, 1991, 23:2977-2983.
2Berney T, Buhler LH, Majno P, et al.Immunosuppression for pancreatic islet transplantation. Transplant Proc, 2004,36(Suppl) : 362-366.
3Robertson RP, Davis C, Larsen J, et al. Pancreas and islet transplantation for patients with diabetes. Diabetes Care,2000, 23: 112-116.
4Paty BW, Harmon JS, Marsh CL, et al. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets.Transplantation, 2002,73 : 353-357.
5Saleem TF, Cunningham KE, Hollenbeak CS,et al. Development of diabetes mellitus post-renal transplantation is associated with poor short term clinical outcomes. Transplant Proc, 2003, 35:2916-2918.
6Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplan-tation:2003 International Consensus Guidelines. Proceedings of an international expert panel meeting. Barcelona,Spain, 19 February 2003. Transplantation, 2003,75 ( 10 Suppl) : S3-S24.
8Drachenberg CB, Klassen DK, Weir MR, et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation, 1999, 68:396-402.
9Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using steroid-freeimmunosuppression regimen. N Engl J Med, 2000, 343:230-238.
10Van Hooff JP, Van Duijnhoven EM,Christiaans MH. Tarscrolimus and glu metabolism. Transplant Proc,1999,31 : 49S-50S.
